Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple bike test could revolutionize lung cancer risk assessment

NCT ID NCT07506889

Knowledge-focused Sponsor: Linkoeping University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test if a simple, low-intensity cycling exercise combined with a handheld monitor can predict serious complications in lung cancer patients before surgery or other treatments. Researchers will include 500 adults with suspected lung cancer. The goal is to make risk assessment easier and more accessible than current complex tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide a simple, low-cost exercise test to better predict which lung cancer patients are at high risk for complications after surgery or during treatment.
What could go wrong
This is an observational study, not a treatment trial. The test may not prove accurate enough to change clinical practice, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients referred for suspected lung cancer to one out of five Department of Pulmonology in Sweden will be asked to participate in study. Patients will perform a low-workload exercise test with measurement of end-tidal carbon dioxide with a handheld equipment. Patients in who further work-up dimiss lung cancer diagnosis will be excluded.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Lung Cancer Diagnosis * Age of at least 18 years Exclusion Criteria: * Not able to perform cycle ergometer exercise * Not able to understand spoken or written Swedish

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End tidal carbon dioxide are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

disease lung cancer lung neoplasm Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

End tidal carbon dioxide Exercise Lobectomy Lung cancer (diagnosis) Neoadjuvant chemoimmunotherapy Surgery--complications

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Clinical Physiology

    Lund, Sweden

  • Department of Pulmonology, Blekinge Hospital

    Karlskrona, Sweden

  • Department of Pulmonology, Kalmar County Hospital

    Kalmar, Sweden

  • Department of Pulmonology, Ryhov

    Jönköping, Sweden

  • Department of Pulmonology, University Hospital

    Linköping, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.